Empower Clinics Launches Improved Line of CBD Products and Confirms 2020 Hemp Handlers Licence for Extraction Facility in Oregon – Yahoo Finance

Empowers’ CBD product line Sollievo has been reformulated to include 900mg of CBD

VANCOUVER BC / ACCESSWIRE / February 19, 2020 / EMPOWER CLINICS INC. (CBDT.CN) (EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company is pleased to announce it has launched a series of re-formulated versions of it’s CBD tincture product line SOLLIEVO. Italian for Relief.

The new formulated Sollievo is non-GMO, non-psychoactive, has rapid bioavailability and is sourced from USA grown hemp. The products are all third-party lab tested for quality, and the new terpene profiles for each of the four tincture categories of Chronic Pain, Digestion, Insomnia and Anxiety, are aimed to promote mind and body wellness.

“We have spent the last few months dramatically increasing the potency, flavour profiles, and profitability of the Sollievo tincture product lines”, said Dustin Klein, SVP Business Development and Director, Empower Clinics Inc. “Our new formulations were manufactured in a state-of-the-art CGMP facility, ensuring quality and consistency, and by tripling the amount of CBD per unit to 900mg, it provides a more potent single dose to our customers, to our patients.”

The new Sollievo tincture lines are now available in the Sun Valley Health wellness clinics, are available online and will be a standard product offering in the Sun Valley Health franchise locations.

The Company also announces it has been awarded its 2020 Oregon Department of Agriculture hemp handlers license, ensuring that the new Sandy, OR extraction and production facility is compliant and licensed to operate under the regulatory framework of the State.

“I’m excited to have our new Sollievo tinctures available for purchase, and so proud of Dustin and our team who have brought an exemplary product to market.” said Steven McAuley, Chairman & CEO of Empower. “Having the hemp handlers license in place for 2020 and continuing toward the close of our Heritage Cannabis joint venture, allows us to control our supply chain and to bring best-in-class CBD products to domestic and international markets.”

The Company also advises that Mat Lee’s position as CFO has concluded and we thank Mat for his contributions. The Company continues to be supported by Invictus Accounting and its team of specialists, who have been integral to creating financial and accounting controls that allow us to report quarterly results well in advance of requirements. The Company has commenced a search for a new Chief Financial Officer.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley
Chairman & CEO
s.mcauley@empowerclinics.com
604-789-2146

Investors: Dustin Klein
SVP, Business Development
dustin@svmmjcc.com
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: rs@maricom.ca, T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Source: https://finance.yahoo.com/news/empower-clinics-launches-improved-line-113000152.html